Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis. The company is experienced at overcoming the bottlenecks involved in mRNA-based R&D with reliable, high-purity manufacturing, and an approach rooted in a quality-first culture and deep regulatory experience.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/12/21 | undisclosed | Seed |
Alloy Therapeutics Vermont Center for Emerging Technologies (VCET) | undisclosed |
| 06/27/23 | $20,000,000 | Venture |
Ampersand Ventures Charles River Laboratories Dynamk Capital Vermont Center for Emerging Technologies (VCET) | undisclosed |
